C12N2320/30 - page 7 - CPC Classification Index

#1801

20120059046

2012-03-08

Inhibition of MAP4K4 through RNAI

#1802

20120058915

2012-03-08

Method of diagnosing poor survival prognosis colon cancer using miR-10a

#1803

20120058914

2012-03-08

Method of diagnosing poor survival prognosis colon cancer using miR-203

#1804

20120058913

2012-03-08

Method of diagnosing poor survival prognosis colon cancer using miR-16b

#1805

20120058912

2012-03-08

Method of diagnosing poor survival prognosis colon cancer using let-7g

#1806

20120058911

2012-03-08

Method of diagnosing poor survival prognosis colon cancer using miR-181b

#1807

20120058108

2012-03-08

METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES

#1808

20120058105

2012-03-08

METHOD OF TREATMENT OF VASCULAR COMPLICATIONS

#1809

20120053234

2012-03-01

Hepcidin binding nucleic acids

#1810

20120053226

2012-03-01

Oligonucleotide analogs as therapeutic agents

#1811

20120046346

2012-02-23

Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs

#1812

20120046343

2012-02-23

Multi-targeting short interfering RNAs

#1813

20120041050

2012-02-16

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1814

20120039914

2012-02-16

MIF antagonists

#1815

20120035248

2012-02-09

Method for inhibiting the activity of mir-155

#1816

20120035240

2012-02-09

Conserved HBV and HCV sequences useful for gene silencing

#1817

20120029060

2012-02-02

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1818

20120029059

2012-02-02

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1819

20120029058

2012-02-02

Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof

#1820

20120029057

2012-02-02

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1821

20120027803

2012-02-02

Biodegradable lipids for the delivery of active agents

#1822

20120022145

2012-01-26

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1823

20120022144

2012-01-26

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1824

20120022132

2012-01-26

Compositions and methods for inhibiting expression of mutant EGFR gene

#1825

20120021516

2012-01-26

Structurally designed shRNAs

#1826

20120010271

2012-01-12

Single-stranded nucleic acid molecule for controlling gene expression

#1827

20110319475

2011-12-29

Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF

#1828

20110319469

2011-12-29

SNPs of apolipoprotein B and modulation of their expression

#1829

20110313025

2011-12-22

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#1830

20110313020

2011-12-22

UNA oligomer structures for therapeutic agents

#1831

20110312086

2011-12-22

Modulation of exon recognition in pre-mRNA by interfering RNA structure

#1832

20110306652

2011-12-15

Compositions and their uses directed to huntingtin

#1833

20110301229

2011-12-08

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#1834

20110301224

2011-12-08

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1835

20110301221

2011-12-08

DIAGNOSIS, PROGNOSIS AND TREATMENT OF GLIOBLASTOMA MULTIFORME

#1836

20110294868

2011-12-01

MODULATION OF TRANSTHYRETIN EXPRESSION

#1837

20110293698

2011-12-01

Reagents and methods for treating cancer

#1838

20110288158

2011-11-24

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#1839

20110288157

2011-11-24

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

#1840

20110275534

2011-11-10

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform

#1841

20110269820

2011-11-03

Spinal muscular atrophy treatment via targeting SMN2 catalytic core

#1842

20110263686

2011-10-27

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

#1843

20110257384

2011-10-20

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#1844

20110257246

2011-10-20

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

#1845

20110256150

2011-10-20

Modulation of axon degeneration

#1846

20110251259

2011-10-13

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

#1847

20110250204

2011-10-13

Methods and compositions for diagnosing and treating diseases

#1848

20110244562

2011-10-06

RNA interference suppression of neurodegenerative diseases and methods of use thereof

#1849

20110243894

2011-10-06

METHODS OF TREATING HEPATITIS C VIRUS INFECTION

#1850

20110237643

2011-09-29

Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity

#1851

20110230410

2011-09-22

Low density lipoprotein receptor-mediated siRNA delivery

#1852

20110229557

2011-09-22

Double-stranded oligonucleotide compound for down-regulating the expression of CASP2 gene

#1853

20110224282

2011-09-15

iRNA agents targeting VEGF

#1854

20110224277

2011-09-15

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#1855

20110224149

2011-09-15

Polynucleotides for use in treating and diagnosing cancers

#1856

20110223656

2011-09-15

MicroRNAs and Uses Thereof

#1857

20110223127

2011-09-15

SDF-1 binding nucleic acids and the use thereof

#1858

20110213007

2011-09-01

MicroRNAs and uses thereof

#1859

20110207224

2011-08-25

In vivo production of small interfering RNAs that mediate gene silencing

#1860

20110200620

2011-08-18

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

#1861

20110184046

2011-07-28

Compositions And Methods For Inhibiting Expression Of GSK-3 Genes

#1862

20110179501

2011-07-21

Methods for reverting methylation by targeting methyltransferases

#1863

20110178157

2011-07-21

Modulation of HSP47 expression

#1864

20110172418

2011-07-14

ANTISENSE RESTENOSIS COMPOSITION AND METHOD

#1865

20110172293

2011-07-14

Methods and Compositions for Modulating Angiogenesis

#1866

20110172291

2011-07-14

RNA interference for the treatment of gain-of-function disorders

#1867

20110166212

2011-07-07

Gene expression and pain

#1868

20110166082

2011-07-07

Antisense composition and method for treating muscle atrophy

#1869

20110143436

2011-06-16

Compositions and methods for reprogramming eukaryotic cells

#1870

20110142815

2011-06-16

Compounds, composition, methods, targets for cancer therapy

#1871

20110142767

2011-06-16

RNAi-mediated inhibition of tumor necrosis factor α-related conditions

#1872

20110135646

2011-06-09

Genes of an otitis media isolate of nontypeable

#1873

20110130443

2011-06-02

Compositions and methods for inhibiting expression of factor V

#1874

20110112172

2011-05-12

SDF-1 binding nucleic acids

#1875

20110104255

2011-05-05

THERAPEUTIC AGENT FOR FIBROID LUNG

#1876

20110092572

2011-04-21

Modulation of growth hormone receptor expression and insulin-like growth factor expression

#1877

20110086044

2011-04-14

Compositions and Methods to Inhibit HPV Infection

#1878

20110081717

2011-04-07

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

#1879

20110077286

2011-03-31

Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof

#1880

20110076335

2011-03-31

Lipid formulations for nucleic acid delivery

#1881

20110065908

2011-03-17

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1882

20110060030

2011-03-10

Modulation of apolipoprotein C-III expression

#1883

20110054009

2011-03-03

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders

#1884

20110054008

2011-03-03

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

#1885

20110046209

2011-02-24

RNA-induced translational silencing and cellular apoptosis

#1886

20110046203

2011-02-24

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1887

20110046200

2011-02-24

Use of antisense oligonucleotides to effect translation modulation

#1888

20110039910

2011-02-17

Modulation of apolipoprotein (a) expression

#1889

20110021605

2011-01-27

MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE

#1890

20110020321

2011-01-27

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

#1891

20110015258

2011-01-20

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1892

20110015253

2011-01-20

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#1893

20110008320

2011-01-13

Further Use of Protein Kinase N Beta

#1894

20100330617

2010-12-30

Methods of producing a secreted protein

#1895

20100324121

2010-12-23

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1896

20100324117

2010-12-23

Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

#1897

20100317719

2010-12-16

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

#1898

20100316707

2010-12-16

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

#1899

20100311816

2010-12-09

MCP-1 binding nucleic acids and use thereof

#1900

20100303859

2010-12-02

Vectors and method for genetic immunization

#1901

20100298408

2010-11-25

Oligonucleotide Compositions with Enhanced Efficiency

#1902

20100292310

2010-11-18

Micro-RNA scaffolds and non-naturally occurring micro-RNAs

#1903

20100292159

2010-11-18

Method of treatment or prophylaxis of inflammatory pain

#1904

20100286378

2010-11-11

Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor

#1905

20100285073

2010-11-11

Micro-RNA family that modulates fibrosis and uses thereof

#1906

20100273860

2010-10-28

Modulation of apolipoprotein (A) expression

#1907

20100267813

2010-10-21

Method for inhibiting the activity of mir-155

#1908

20100261781

2010-10-14

Multivalent aptamer complexes

#1909

20100257618

2010-10-07

Method of diagnosing poor survival prognosis colon cancer using microRNA-21

#1910

20100256222

2010-10-07

Micro-RNA scaffolds, non-naturally occurring micro-RNAs, and methods for optimizing non-naturally occurring micro-RNAs

#1911

20100249215

2010-09-30

Oligomeric compounds and compositions for use in modulation of pri-miRNAs

#1912

20100239546

2010-09-23

BACTERIAL MEDIATED TNF ALPHA GENE SILENCING

#1913

20100234448

2010-09-16

Vivo production of small interfering RNAs that mediate gene silencing

#1914

20100233810

2010-09-16

In vivo production of small interfering RNAS that mediate gene silencing

#1915

20100233195

2010-09-16

Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof

#1916

20100215729

2010-08-26

Oligonucleotide analogues incorporating 5-aza-cytosine therein

#1917

20100209487

2010-08-19

Nicked or gapped nucleic acid molecules and uses thereof

#1918

20100209357

2010-08-19

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

#1919

20100184032

2010-07-22

Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof

#1920

20100178272

2010-07-15

STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES

#1921

20100175141

2010-07-08

Tunable genetic switch for regulating gene expression

#1922

20100172882

2010-07-08

COMPOSITIONS AND METHODS FOR TARGETED INACTIVATION OF HIV CELL SURFACE RECEPTORS

#1923

20100168205

2010-07-01

Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules

#1924

20100166676

2010-07-01

RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS

#1925

20100159030

2010-06-24

METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TURMORGENICITY

#1926

20100152279

2010-06-17

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

#1927

20100144844

2010-06-10

RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis

#1928

20100144832

2010-06-10

Prostate cancer-specific alternations in ERG gene expression and detection and treatment methods based on those alterations

#1929

20100144831

2010-06-10

BLOCKING OF GENE EXPRESSION IN EUKARYOTIC CELLS

#1930

20100137411

2010-06-03

RAS-MEDIATED EPIGENETIC SILENCING EFFECTORS AND USES THEREOF

#1931

20100130595

2010-05-27

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

#1932

20100130591

2010-05-27

Multiple exon skipping compositions for DMD

#1933

20100120893

2010-05-13

Compositions and methods for inhibiting expression of transthyretin

#1934

20100104587

2010-04-29

Methods of modulating the negative chemotaxis of immune cells

#1935

20100093832

2010-04-15

Modulation of insulin like growth factor I receptor expression in cancer

#1936

20100092524

2010-04-15

Modification of exosomal components for use as a vaccine

#1937

20100092438

2010-04-15

Bacteria mediated gene silencing

#1938

20100087511

2010-04-08

Spinal muscular atrophy (SMA) treatment via targeting of splice site inhibitory sequences

#1939

20100081710

2010-04-01

Modified L-Nucleic Acid

#1940

20100069472

2010-03-18

COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN

#1941

20100069465

2010-03-18

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1942

20100069461

2010-03-18

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V LEIDEN MUTANT GENE

#1943

20100011654

2010-01-21

RNAi for the control of insects and arachnids

#1944

20100004436

2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1945

20100004435

2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1946

20100004434

2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1947

20100004318

2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1948

20100004317

2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1949

20100003758

2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1950

20090326046

2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1951

20090325286

2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1952

20090325285

2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1953

20090325181

2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1954

20090324612

2009-12-31

MODULATING NEURONAL OUTGROWTH VIA THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I (MHC I) MOLECULE

#1955

20090324596

2009-12-31

Methods of identifying and treating poor-prognosis cancers

#1956

20090324507

2009-12-31

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

#1957

20090318536

2009-12-24

Methods for treating hypercholesterolemia

#1958

20090317907

2009-12-24

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1959

20090306176

2009-12-10

Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors

#1960

20090298174

2009-12-03

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1961

20090291907

2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1962

20090291906

2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1963

20090291131

2009-11-26

Silencing of polo-like kinase expression using interfering RNA

#1964

20090286969

2009-11-19

Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs

#1965

20090286853

2009-11-19

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

#1966

20090286714

2009-11-19

Molecules of the card-related protein family and uses thereof

#1967

20090281167

2009-11-12

Compositions and methods related to miRNA modulation of neovascularization or angiogenesis

#1968

20090275884

2009-11-05

Use of nucleic acids with reduced pressure therapy

#1969

20090270481

2009-10-29

Modified siRNA molecules and uses thereof

#1970

20090263404

2009-10-22

Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor

#1971

20090246875

2009-10-01

Efficient method for nuclear reprogramming

#1972

20090221678

2009-09-03

Compositions and methods for treatment of prostate and other cancers

#1973

20090220582

2009-09-03

Method of cancer treatment using siRNA silencing

#1974

20090215860

2009-08-27

COMPOSITIONS AND METHODS FOR REGULATING GENE TRANSCRIPTION

#1975

20090214518

2009-08-27

Methods and compositions for treating solid tumors and enhancing tumor vaccines

#1976

20090209748

2009-08-20

Oligonucleotides with alternating segments of locked and non-locked nucleotides

#1977

20090209627

2009-08-20

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

#1978

20090208564

2009-08-20

Compositions of asymmetric interfering RNA and uses thereof

#1979

20090176723

2009-07-09

Methods and compositions involving miRNA and miRNA inhibitor molecules

#1980

20090170204

2009-07-02

Cosmetic designs and products using intronic RNA

#1981

20090156539

2009-06-18

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

#1982

20090142295

2009-06-04

Methods of treatment by administering anti-connexin proteins and mimetics

#1983

20090133136

2009-05-21

Inducible SIRNA expression cassette and method of use

#1984

20090131358

2009-05-21

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

#1985

20090130751

2009-05-21

Reduction of off-target RNA interference toxicity

#1986

20090124566

2009-05-14

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES

#1987

20090093434

2009-04-09

USE OF EIF-5A1 SIRNA TO PROTECT ISLETS CELLS FROM APOPTOSIS AND TO PRESERVE THEIR FUNCTIONALITY

#1988

20090082291

2009-03-26

Methods of treatment of acute renal failure

#1989

20090076246

2009-03-19

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

#1990

20090075924

2009-03-19

Modulation of apolipoprotein (a) expression

#1991

20090062196

2009-03-05

Compositions and methods of treating cancer

#1992

20090043083

2009-02-12

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1993

20090036395

2009-02-05

RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF

#1994

20090018321

2009-01-15

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#1995

20090010948

2009-01-08

ANTI-TUMOR VACCINES DELIVERED BY DENDRITIC CELLS DEVOID OF INTERLEUKIN-10

#1996

20080311081

2008-12-18

Bacteria mediated gene silencing

#1997

20080306006

2008-12-11

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of solid cancers

#1998

20080300209

2008-12-04

Gene expression and pain

#1999

20080292618

2008-11-27

Intranuclear protein transduction through a nucleoside salvage pathway

#2000

20080287382

2008-11-20

Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases

#2001

20080287380

2008-11-20

Antisense oligonucleotides against cPLA, compositions and uses thereof

#2002

20080287379

2008-11-20

Oligonucleotide complex compositions and methods of use as gene alteration tools

#2003

20080280298

2008-11-13

SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTASIS

#2004

20080269474

2008-10-30

ShRNA molecules and methods of use thereof

#2005

20080269157

2008-10-30

Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations

#2006

20080267956

2008-10-30

Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis

#2007

20080261908

2008-10-23

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer

#2008

20080261304

2008-10-23

METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS

#2009

20080242632

2008-10-02

Multi-targeting short interfering RNAs

#2010

20080214485

2008-09-04

Method of inducing an immune response

#2011

20080214437

2008-09-04

Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases

#2012

20080206154

2008-08-28

Single-stranded antimicrobial oligonucleotides and uses thereof

#2013

20080200420

2008-08-21

In vivo production of small interfering RNAs that mediate gene silencing

#2014

20080200409

2008-08-21

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

#2015

20080176766

2008-07-24

Methods and compositions involving miRNA and miRNA inhibitor molecules

#2016

20080171715

2008-07-17

Methods and compositions involving miRNA and miRNA inhibitor molecules

#2017

20080161236

2008-07-03

Therapeutic nucleic acid-3′-conjugates

#2018

20080153772

2008-06-26

Oligonucleotides for RNA interference and biological applications thereof

#2019

20080153162

2008-06-26

Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon

#2020

20080146507

2008-06-19

Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor

#2021

20080119427

2008-05-22

Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation

#2022

20080050744

2008-02-28

Methods and compositions involving miRNA and miRNA inhibitor molecules

#2023

20080039418

2008-02-14

Compositions and their uses directed to huntingtin

#2024

20070299027

2007-12-27

COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN

#2025

20070292408

2007-12-20

Spinal muscular atrophy (SMA) treatment via targeting of splice site inhibitory sequences

#2026

20070281901

2007-12-06

RNAI-mediated inhibition of tumor necrosis factor α-related conditions

#2027

20070265215

2007-11-15

Antisense restenosis composition and method

#2028

20070218032

2007-09-20

B7-H4 expression on tumor vasculature

#2029

20070185047

2007-08-09

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2030

20070185046

2007-08-09

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2031

20070179160

2007-08-02

Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer

#2032

20070179109

2007-08-02

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2033

20070179108

2007-08-02

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2034

20070179107

2007-08-02

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2035

20070179106

2007-08-02

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2036

20070173475

2007-07-26

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2037

20070173474

2007-07-26

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2038

20070172948

2007-07-26

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2039

20070167392

2007-07-19

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2040

20070167391

2007-07-19

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2041

20070167390

2007-07-19

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2042

20070167385

2007-07-19

Antisense oligonucleotides (ODN) against Smad7 and uses in medical field thereof

#2043

20070166734

2007-07-19

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2044

20070155690

2007-07-05

RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis

#2045

20070135372

2007-06-14

Modified siRNA molecules and uses thereof

#2046

20070123484

2007-05-31

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#2047

20070122821

2007-05-31

Antisense composition and method for treating muscle atrophy

#2048

20070072796

2007-03-29

Oligonucleotide analogues incorporating 5-aza-cytosine therein

#2049

20070050146

2007-03-01

Micrornas and uses thereof

#2050

20070042985

2007-02-22

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

#2051

20070003575

2007-01-04

Viral and viral associated miRNAs and uses thereof

#2052

20060281698

2006-12-14

Modulation of apolipoprotein (A) expression

#2053

20060276424

2006-12-07

Compositions and methods for treatment of prostate and other cancers

#2054

20060264395

2006-11-23

Modulation of apolipoprotein c-III expression

#2055

20060252722

2006-11-09

Oligomeric compounds and compositions for use in modulation of pri-mirnas

#2056

20060223770

2006-10-05

IRNA agents targeting VEGF

#2057

20060205635

2006-09-14

Antigene oligomers inhibit transcription

#2058

20060178334

2006-08-10

Double-stranded and single-stranded RNA molecules with 5 ' triphosphates and their use for inducing interferon

#2059

20060178325

2006-08-10

Modulation of growth hormone receptor expression and insulin-like growth factor expression

#2060

20060172961

2006-08-03

RNAi inhibition of serum amyloid a for treatment of glaucoma

#2061

20060166910

2006-07-27

RNA-interference by single-stranded RNA molecules

#2062

20060147952

2006-07-06

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

#2063

20060128646

2006-06-15

Amino-LNA, thio-LNA and alpha-L-oxy-LN

#2064

20060099616

2006-05-11

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

#2065

20060094110

2006-05-04

Use of spliceosome mediated RNA trans-splicing for immunotherapy

#2066

20060094032

2006-05-04

iRNA agents targeting VEGF

#2067

20060083744

2006-04-20

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

#2068

20060073127

2006-04-06

Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules

#2069

20060069056

2006-03-30

Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases

#2070

20060040886

2006-02-23

Compositions and methods for treatment of prostate and other cancers

#2071

20060024754

2006-02-02

Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor

#2072

20060014715

2006-01-19

Control of gene expression

#2073

20060014289

2006-01-19

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

#2074

20060009402

2006-01-12

In vivo production of small interfering RNAS that mediate gene silencing

#2075

20060008448

2006-01-12

Inhibition of li expression in mammalian cells

#2076

20060003915

2006-01-05

Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification

#2077

20060003326

2006-01-05

Modified L-nucleic acid

#2078

20050287558

2005-12-29

SNPs of apolipoprotein B and modulation of their expression

#2079

20050277610

2005-12-15

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#2080

20050267060

2005-12-01

Combinatorial methods and compositions for treatment of melanoma

#2081

20050266409

2005-12-01

Compositions and methods for diagnosing, preventing, and treating cancers

#2082

20050261218

2005-11-24

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#2083

20050260755

2005-11-24

Sequential delivery of oligomeric compounds

#2084

20050244858

2005-11-03

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

#2085

20050222061

2005-10-06

Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye

#2086

20050191680

2005-09-01

Therapeutic nucleic acid-3' -conjugates

#2087

20050113325

2005-05-26

Modified oligonucleotides for telomerase inhibition

#2088

20050080246

2005-04-14

Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

#2089

20050058982

2005-03-17

Modified small interfering RNA molecules and methods of use

#2090

20050014264

2005-01-20

Method of introducing siRNA into adipocytes

#2091

16556054

2020-12-01

Homologous recombination directed genome editing in eukaryotes

#2092

16408518

2022-06-14

Strategy to increase anti-viral, anti-microbial, and anti-fungal defense

#2093

14204639

2015-11-24

Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer